Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine in Dilated Cardiomyopathy
NCT02133911Phase 2Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- May 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ranolazine in dilated cardiomyopathy (DCM), sponsored by University Medical Centre Ljubljana. Started May 2014; status: completed.
02
Drugs
ranolazine
03
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT02133911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02133911.